Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BeOne Medicines Ltd. | 142,888,241 | reported | 14 Jun 2023 | tx 4+7,800−1,198,128 |
| ArriVent BioPharma, Inc. | 3,929,117 | reported | 10 Dec 2025 | tx 6+4,484,672−60,317,458 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Dec 2025 | SALE | ArriVent BioPharma, Inc. | 555,555 | 23.37 USD | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 313,076 | — | |
| 30 Jan 2024 | PURCHASE | ArriVent BioPharma, Inc. | 555,555 | 18.00 USD | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 3,616,041 | — | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 55,000,000 | 0.00 USD | deriv |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 4,761,903 | 0.00 USD | deriv |
| 13 Jun 2023 | SALE | BeOne Medicines Ltd. | 313,400 | 128.43 USD | |
| 13 Jun 2023 | SALE | BeOne Medicines Ltd. | 611,000 | 211.45 USD | |
| 14 Jun 2023 | SALE | BeOne Medicines Ltd. | 273,728 | 207.72 USD | |
| 22 Aug 2022 | OTHER | BeOne Medicines Ltd. | 7,800 | 0.00 USD |